skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi 5iTeam,
I noticed that when the markets pulled back in early to mid March this year, both bond ETFs: XLB (approx. -28%) and XSB (approx -9%), pulled back as well although there were no movements in interest rates. I would think that these bond ETFs are a good proxy for cash, then what would investors' reason be for selling? Your comments on this would be much appreciated.
Cheers,
Read Answer Asked by Harry on July 17, 2020
Q: Can you give me your opinion on mrk - it's current valuation and room to grow? Can you recommend five large cap us growth stock with room to grow?
Read Answer Asked by Mary on July 17, 2020
Q: I am planning to increase my bond exposure in my RIF and have looked at VBU. I already have Canadian bond exposure. This is a hedged fund. Is this, as a hedged fund, appropriate for my RIF? Is there an unhedged equivalent? Do you have other funds I should review?

Thanks
Read Answer Asked by Ronald on July 17, 2020
Q: Please rate the above for the following criteria (best first):
Safety, valuation, dividend sustainability,long term strength,
thanks
Read Answer Asked by JOSEPH on July 17, 2020
Q: Prospectus was received indicating IPAY ETF is being acquired by ISE Mobile Payment ETF run by ETC. Prospectus indicate ISE Index have the same investment themes as the index followed by IPAY. Specific constituents and weight may be differ. MER of ISE ETF will be .60% which is lower than IPAY (.75%).
1) The proposed reorganization is expected to be a tax-free transaction for federal income tax purpose. Would this be applicable for Canadian shareholders too? Or do we need to wait from a ruling from CRA?
2) What are your thoughts on this reorganization? Any red flags?
Thank you
Read Answer Asked by Karen on July 17, 2020
Q: Hi 5i Team - I have been reading an article in the Globe and Mail about the resurgence of investor interest in the biotech sector with a number of IPO's either recent or planned. Would you be able to recommend a few Canadian companies in this sector based on the following criteria: solid management, cash reserves for at least one year and preferably more, manageable debt, good growth prospects, any size capitalization but small to mid cap preferred, any risk level but not something that is purely speculative. These companies do not have to be on the forefront of Coronavirus research but could have innovative research into any health platforms. I am also interested in the U.S. side of this but will do this in another question. Thanks.
Rob
Read Answer Asked by Rob on July 17, 2020
Q: Peter, can you shed any light on the dramatic price action following MOGO's financial release. It shot up from 1.25 to 3.45 following the release (175%+) and has now settled back to around 1.70 as I write this. The trader in me would expect some gap filling here, but I have no idea why the stock spiked as sharply as it did.
Read Answer Asked by David on July 16, 2020
Q: I am looking for basic material exposure in either ZMT XBM XMA XLB or VAW. What would be your pick for a comeback in basic material.
Thanks
Read Answer Asked by James on July 16, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!